Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer

NCT07034742 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma

Interventions

DRUG: Intraperitoneal chemotherapy PLUS systemic chemotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences